Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Geriatric Medicine
Would you recommend a GLP-1 agonist as an option to reduce the risk of dementia in patients with a strong family history?
JAMA Neurology. 2025;82(5):450-460. doi:10.1001/jamaneurol.2025.0360.
Related Questions
What is your systolic blood pressure target for patients over 80 with frailty and multiple comorbidities?
How do you counsel older adults regarding the use of melatonin (dose and timing) for sleep-related problems?
Would you use a parathyroid hormone analog for treatment of osteoporosis in a patient with mildly elevated AlkPhos of unclear etiology?
How do you recommend counseling patients on the prognosis of advanced cancer as a generalist who is not highly specialized in cancer literature or cancer-directed therapies?
What suggestions for environmental modifications do you find most helpful to reduce the risk of falls in the geriatric population?
How do you approach individualizing A1c goals in patients with dementia?
Would you start romosozumab in an active smoker?
Do you routinely prescribe vitamin D to reduce the risk of fall-related fractures in elderly patients regardless of their serum levels?
Do you routinely adjust your interpretation of SLUMS and/or MOCA tests in patients depending on their level of education?
What are the best practices for optimizing transitions from hospital to skilled nursing facilities for older adult patients, with specific regard to adapting hospital medication regimens to the skilled nursing facility setting?